Literature DB >> 14568231

Cytokine secretion in nasal mucus of normal subjects and patients with allergic rhinitis.

M C Scavuzzo1, V Rocchi, B Fattori, F Ambrogi, A Carpi, R Ruffoli, S Manganelli, F Giannessi.   

Abstract

Allergic rhinitis is regulated by the local production and release of several cytokines. The levels of Th2 cytokines IL-4, IL-6, IL-10 and the Th1 cytokine IFN-gamma were studied in nasal mucus from 30 subjects with allergic rhinitis and 45 non-atopic healthy controls. In this study a sampling technique for collecting nasal mucus, well tolerated by the subjects and with a minimal stimulation of the mucosa, was performed. The cytokine concentrations in nasal mucus samples were detected and quantitated by a new paramagnetic particle-based immunofluorescent assay system more sensitive than the conventional ELISA techniques. The new technique showed reliable values of the measured parameters. The nasal mucus from allergic patients contained significantly higher concentrations of IL-4 (25.5 +/- 3.6 pg/ml; P < 0.001) and IL-10 (1300 +/- 190 pg/ml; P < 0.05) compared to the nasal mucus from control subjects (15.2 +/- 2.3 and 532 +/- 28 pg/ml, respectively, for IL-4 and IL-10). No significant modification in IFN-gamma levels of allergic patients was found when compared to control group (respectively, 19.9 +/- 3.3 vs. 25.7 +/- 5.1 pg/ml; P > 0.05). Moreover, the allergic patients showed lower levels of IL-6 concentrations in the nasal mucus compared to control subjects (64.8 +/- 9.1 vs. 129.0 +/- 18.1 pg/ml; P = 0.0099). These data can be interpreted by the hypothesis that in response to environmental allergens there is a preferential Th2 polarity by activated CD4+ T cells and that the cytokines IL-6 and IL-10 have, respectively, an important anti-inflammatory and counterregulatory action in the pathogenesis of allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568231     DOI: 10.1016/s0753-3322(03)00097-0

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  The normative value of inflammatory cells in the nasal perfusate of Chinese adults: a pilot study.

Authors:  Yong Zhang; Qiuping Wang; Yanqing Xie; Zhiyi Wang; Derong Li; Li Ma; Xinju Pang; Weidong Yu; Nanshan Zhong
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

2.  Serum and local IL-4, IL-5, IL-13 and immunoglobulin E in allergic rhinitis.

Authors:  Atanas Nachev Vlaykov; Tanya Tacheva Tacheva; Tatyana Ivanova Vlaykova; Valentin Kostov Stoyanov
Journal:  Postepy Dermatol Alergol       Date:  2020-11-07       Impact factor: 1.837

3.  Association between promoter polymorphisms of interleukin-4 gene and allergic rhinitis risk: a meta-analysis.

Authors:  Zhi-Peng Li; Li-Li Yin; Hui Wang; Li-Si Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

4.  Eosinophil Chemokines and Clara Cell Protein 16 Production in Nasal Mucosa of Patients with Persistent Allergic Rhinitis.

Authors:  Aleksandar Perić; Cveta Špadijer Mirković; Biserka Vukomanović Đurđević; Aneta V Perić; Danilo Vojvodić
Journal:  Eurasian J Med       Date:  2017-10

5.  Heat shock protein 70 and anti-heat shock protein 70 antibodies in nasal secretions of patients with chronic rhinosinusitis.

Authors:  Namjil N Tsybikov; Elena V Egorova; Boris I Kuznik; Elena V Fefelova; Eli Magen
Journal:  Allergy Rhinol (Providence)       Date:  2016-01

6.  Granulocyte-Macrophage Colony-Stimulating Factor Production and Tissue Eosinophilia in Chronic Rhinitis.

Authors:  Aleksandar Peric; Cveta Spadijer-Mirkovic; Svjetlana Matkovic-Jozin; Ljiljana Jovancevic; Danilo Vojvodic
Journal:  Int Arch Otorhinolaryngol       Date:  2016-02-26

7.  Changes in inflammatory biomarkers in the nasal mucosal secretion after septoplasty.

Authors:  Marn Joon Park; Yong Ju Jang
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

8.  Combining MucilAir™ and Vitrocell® Powder Chamber for the In Vitro Evaluation of Nasal Ointments in the Context of Aerosolized Pollen.

Authors:  Julia Metz; Katharina Knoth; Henrik Groß; Claus-Michael Lehr; Carolin Stäbler; Udo Bock; Marius Hittinger
Journal:  Pharmaceutics       Date:  2018-05-10       Impact factor: 6.321

Review 9.  An unexpected biomaterial against SARS-CoV-2: Bio-polyphosphate blocks binding of the viral spike to the cell receptor.

Authors:  Werner E G Müller; Heinz C Schröder; Meik Neufurth; Xiaohong Wang
Journal:  Mater Today (Kidlington)       Date:  2021-08-02       Impact factor: 31.041

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.